; (B) with respect to a fiscal year that is after the first fiscal year in which the advanced CKD practitioner participates in the advanced CKD demonstration program, is adjusted based on the performance of the practitioner during the prior fiscal year with respect to the measures developed by the Secretary pursuant to paragraph (3); (C) is determined through the use of a computation that is developed in consultation with— (i) chronic kidney disease patient advocates; (ii) clinicians in the nephrology community; (iii) experts in the development of evidence-based guidelines for the detection, diagnosis, and management of chronic kidney disease